40 related articles for article (PubMed ID: 16236631)
21. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
22. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
23. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
[TBL] [Abstract][Full Text] [Related]
25. [Transduction of hematopoietic stem cells by lentiviral vectors].
Miyoshi H
Uirusu; 2002 Dec; 52(2):225-31. PubMed ID: 12685312
[No Abstract] [Full Text] [Related]
26. Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases.
Poletti V; Mavilio F
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452394
[TBL] [Abstract][Full Text] [Related]
27. Determination of functional viral titer by drug-resistance colony assay, expression of green fluorescent protein, and beta-galactoside staining.
Tonini T; Claudio PP; Giordano A; Romano G
Methods Mol Biol; 2004; 285():149-53. PubMed ID: 15269409
[No Abstract] [Full Text] [Related]
28. Lentiviral vectors for the gene therapy of lympho-hematological disorders.
Salmon P; Trono D
Curr Top Microbiol Immunol; 2002; 261():211-27. PubMed ID: 11892249
[No Abstract] [Full Text] [Related]
29. Fluorescent genetic barcoding for cellular multiplex analyses.
Maetzig T; Morgan M; Schambach A
Exp Hematol; 2018 Nov; 67():10-17. PubMed ID: 30098396
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral vectors for the genetic modification of hematopoietic stem cells.
Trono D
Ernst Schering Res Found Workshop; 2001; (33):19-28. PubMed ID: 11105251
[No Abstract] [Full Text] [Related]
31. Expression and recombination of the EGFP and EYFP genes in lentiviral vectors carrying two heterologous promoters.
Dijon M; Torne-Celer C; Moreau T; Tonnelle C; Chabannon C
Cytotherapy; 2005; 7(5):417-26. PubMed ID: 16236631
[TBL] [Abstract][Full Text] [Related]
32. Real-time quantitative PCR for the design of lentiviral vector analytical assays.
Delenda C; Gaillard C
Gene Ther; 2005 Oct; 12 Suppl 1():S36-50. PubMed ID: 16231054
[TBL] [Abstract][Full Text] [Related]
33. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
Dropulic B
Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
[TBL] [Abstract][Full Text] [Related]
34. "Rainbow" reporters for multispectral marking and lineage analysis of hematopoietic stem cells.
Hawley TS; Telford WG; Hawley RG
Stem Cells; 2001; 19(2):118-24. PubMed ID: 11239166
[TBL] [Abstract][Full Text] [Related]
35. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
Logan AC; Lutzko C; Kohn DB
Curr Opin Biotechnol; 2002 Oct; 13(5):429-36. PubMed ID: 12459333
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
